Therefore, AML patients with aberrant cytoplasmic localization of NPM1 may have compromised nucleolar/nucleoplasm pathways, affecting their genomic integrity and promoting genomic abnormalites. The gene discussed is NPM1; the disease is acute myeloid leukemia.